CLINICAL_TRIALS
trial_result
· 2020-04-21
Clinical Trial Update: Erlotinib Prevention of Oral Cancer (EPOC) [Phase 3]
Summary
Phase 3 trial update on erlotinib for prevention of oral cancer has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Oral Cancer | Phase 3 | Status: COMPLETED | Results posted: 2020-04-21